TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/25 17:30 | 5/8/25 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byam Rebecca | FL | O | CFO | P.d | 220 | 26.00 | 0 | 8 | 24 | 43 | D | ||||||||||||||
10/23/23 16:44 | 10/19/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byam Rebecca | FL | O | CFO | M.d | 7 | 0.1400 | 0 | 47 | 8 | 621 | D | ||||||||||||||
9/15/23 18:52 | 9/13/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byam Rebecca | FL | O | CFO | P | 10 | 2.10 | 0 | 5 | 1 | 574 | D | ||||||||||||||
9/13/23 17:33 | 9/11/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byam Rebecca | FL | O | CFO | P.m | 21 | 2.07 | 0 | 10 | 2 | 569 | D | ||||||||||||||
9/8/23 17:25 | 9/7/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byam Rebecca | FL | O | CFO | P.m | 20 | 1.99 | 0 | 10 | 2 | 559 | D | ||||||||||||||
9/7/23 16:47 | 9/6/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byam Rebecca | FL | O | CFO | P | 10 | 1.95 | 0 | 5 | 1 | 549 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |